Dystrophic Epidermolysis Bullosa (DEB) Treatment Market
Introduction The Dystrophic Epidermolysis Bullosa (DEB) Treatment Market is evolving rapidly due to increasing awareness, rising prevalence of rare genetic disorders, and ongoing advancements in gene and regenerative therapies. DEB, a severe form of epidermolysis bullosa, requires targeted therapeutic approaches for symptom management and long-term